Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Hashimoto

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Physical Review Letters|October 2, 2019
All-Optical Storage of Phase-Sensitive Quantum States of LightYosuke Hashimoto, Takeshi Toyama, Jun-Ichi Yoshikawa, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 16, 2018
Safety evaluation of a human chimeric monoclonal antibody that recognizes the extracellular loop domain of claudin-2Yosuke Hashimoto, Tomoyuki Hata, Minoru Tada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinomaEiji Tanaka, Yosuke Hashimoto, Tetsuo Ito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Prognostic significance of fascin overexpression in human esophageal squamous cell carcinomaYosuke Hashimoto, Tetsuo Ito, Harutaka Inoue, et al.
Brain : a Journal of Neurology|June 17, 2022
Recurrent de novo mutations in CLDN5 induce an anion-selective blood-brain barrier and alternating hemiplegiaYosuke Hashimoto, Karine Poirier, Nathalie Boddaert, et al.
Journal of Neurosurgery. Case Lessons|November 1, 2022
New aneurysm formation and regrowth associated with rebleeding of residual pediatric ruptured arteriovenous malformation: patient seriesYoshihisa Matsumoto, Yui Nagata, Setsuko Nakagawa, et al.
Scientific Reports|June 1, 2018
Engineered membrane protein antigens successfully induce antibodies against extracellular regions of claudin-5Yosuke Hashimoto, Wei Zhou, Kohtaroh Hamauchi, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 21, 2018
A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomesTaro Shimizu, Amr S Abu Lila, Risako Fujita, et al.
Pharmaceutical Research|October 4, 2018
A Cell Assay for Detecting Anti-PEG Immune Response against PEG-Modified TherapeuticsTaro Shimizu, Amr S Abu Lila, Mizuki Awata, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 12, 2021
Safety and efficacy of an anti-claudin-5 monoclonal antibody to increase blood-brain barrier permeability for drug delivery to the brain in a non-human primateKeisuke Tachibana, Yosuke Hashimoto, Keisuke Shirakura, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Physical Review Letters|October 2, 2019
All-Optical Storage of Phase-Sensitive Quantum States of LightYosuke Hashimoto, Takeshi Toyama, Jun-Ichi Yoshikawa, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 16, 2018
Safety evaluation of a human chimeric monoclonal antibody that recognizes the extracellular loop domain of claudin-2Yosuke Hashimoto, Tomoyuki Hata, Minoru Tada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinomaEiji Tanaka, Yosuke Hashimoto, Tetsuo Ito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Prognostic significance of fascin overexpression in human esophageal squamous cell carcinomaYosuke Hashimoto, Tetsuo Ito, Harutaka Inoue, et al.
Brain : a Journal of Neurology|June 17, 2022
Recurrent de novo mutations in CLDN5 induce an anion-selective blood-brain barrier and alternating hemiplegiaYosuke Hashimoto, Karine Poirier, Nathalie Boddaert, et al.
Journal of Neurosurgery. Case Lessons|November 1, 2022
New aneurysm formation and regrowth associated with rebleeding of residual pediatric ruptured arteriovenous malformation: patient seriesYoshihisa Matsumoto, Yui Nagata, Setsuko Nakagawa, et al.
Scientific Reports|June 1, 2018
Engineered membrane protein antigens successfully induce antibodies against extracellular regions of claudin-5Yosuke Hashimoto, Wei Zhou, Kohtaroh Hamauchi, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 21, 2018
A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomesTaro Shimizu, Amr S Abu Lila, Risako Fujita, et al.
Pharmaceutical Research|October 4, 2018
A Cell Assay for Detecting Anti-PEG Immune Response against PEG-Modified TherapeuticsTaro Shimizu, Amr S Abu Lila, Mizuki Awata, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 12, 2021
Safety and efficacy of an anti-claudin-5 monoclonal antibody to increase blood-brain barrier permeability for drug delivery to the brain in a non-human primateKeisuke Tachibana, Yosuke Hashimoto, Keisuke Shirakura, et al.
Pageof 8